Literature DB >> 4332808

DNA in uninfected and virus-infected cells complementary to avian tumor virus RNA.

P N Rosenthal, H L Robinson, W S Robinson, T Hanafusa, H Hanafusa.   

Abstract

The 70S RNA component of several avian tumor viruses was hybridized with DNA extracted from avian tumor virus-infected and uninfected chicken and Japanese quail cells. Tritium-labeled 70S RNAs from Rous sarcoma virus (RSV), Rous associated virus-1 (RAV-1), RAV-60, and Schmidt-Ruppin-RSV (SR-RSV) hybridize from 3 to 10 times more with DNA from uninfected chicken cells than with DNA from Escherichia coli, calfthymus, or baby hamster kidney cells. After infection of chicken cells with RSV(RAV-1), SR-RSV, or RAV-2, the amount of 70S avian tumor virus [(3)H]RNA hybridized increases by 1.6 times. The specificity of the hybridization reaction was shown by the specific competition of 70S SR-RSV [(3)H]RNA with 70S RNA from RSV(RAV-1), and not with RNA from Sendai virus or chicken cells. There was no difference in the hybridization of 70S RNA from RSV (RAV-1), RAV-1, or RAV-60 with DNA either from chicken cells that contain RAV-60 in a nonreplicating form or from chicken cells that do not appear to contain RAV-60. These results indicate that both types of uninfected chicken cells contain DNA that is complementary to RNA from several avian tumor viruses and that the amount of complementary DNA increases in such cells after infection with an avian tumor virus. The RNAs of genetically different avian tumor viruses appear to have indistinguishable base sequences by this technique.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4332808      PMCID: PMC389416          DOI: 10.1073/pnas.68.10.2336

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  HOMOLOGY BETWEEN RNA FROM ROUS SARCOMA VIROUS AND DNA FROM ROUS SARCOMA VIRUS-INFECTED CELLS.

Authors:  H M TEMIN
Journal:  Proc Natl Acad Sci U S A       Date:  1964-08       Impact factor: 11.205

2.  THE EFFECTS OF ACTINOMYCIN D ON GROWTH OF ROUS SARCOMA VIRUS IN VITRO.

Authors:  H M TEMIN
Journal:  Virology       Date:  1963-08       Impact factor: 3.616

3.  Isolation and characterization of proteins from Rous sarcoma virus.

Authors:  P P Hung; H L Robinson; W S Robinson
Journal:  Virology       Date:  1971-01       Impact factor: 3.616

4.  Inhibition of growth of uninfected and rous sarcoma virus-infected chick-embryo fibroblasts by rifampicin.

Authors:  H L Robinson; W S Robinson
Journal:  J Natl Cancer Inst       Date:  1971-04       Impact factor: 13.506

5.  A cell-associated factor essential for formation of an infectious form of Rous sarcoma virus.

Authors:  H Hanafusa; T Miyamoto; T Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  1970-06       Impact factor: 11.205

6.  RNA-dependent DNA polymerase in virions of RNA tumour viruses.

Authors:  D Baltimore
Journal:  Nature       Date:  1970-06-27       Impact factor: 49.962

7.  A type of chick embryo cell that fails to support formation of infectious RSV.

Authors:  T Hanafusa; T Miyamoto; H Hanafusa
Journal:  Virology       Date:  1970-01       Impact factor: 3.616

8.  Self-annealing of subgroup 2 myxovirus RNAs.

Authors:  W S Robinson
Journal:  Nature       Date:  1970-03-07       Impact factor: 49.962

9.  RNA-dependent DNA polymerase in virions of Rous sarcoma virus.

Authors:  H M Temin; S Mizutani
Journal:  Nature       Date:  1970-06-27       Impact factor: 49.962

10.  Studies on the nature and genetic control of an antigen in normal chick embryos which reacts in the COFAL test.

Authors:  L N Payne; R C Chubb
Journal:  J Gen Virol       Date:  1968-12       Impact factor: 3.891

View more
  51 in total

1.  Structural studies on oncornavirus-related sequences in chicken genomic DNA: two-step analyses of EcoRI and Bgl I restriction digests and tentative mapping of a ubiquitous endogenous provirus digests and tentative mapping of a ubiquitous endogenous provirus.

Authors:  W McClements; H Hanafusa; S Tilghman; A Skalka
Journal:  Proc Natl Acad Sci U S A       Date:  1979-05       Impact factor: 11.205

2.  Recombination between endogenous and exogenous RNA tumor virus genes as analyzed by nucleic acid hybridization.

Authors:  W S Hayward; H Hanafusa
Journal:  J Virol       Date:  1975-06       Impact factor: 5.103

3.  Use of alkaline sucrose gradients in a zonal rotor to detect integrated and unintegrated avian sarcoma virus-specific DNA in cells.

Authors:  H E Varmus; S Heasley; J Linn; K Wheeler
Journal:  J Virol       Date:  1976-05       Impact factor: 5.103

4.  Synethesis and integration of viral DNA in chicken cells at different time after infection with various multiplicities of avian oncornavirus.

Authors:  A T Khoury; H Hanafusa
Journal:  J Virol       Date:  1976-05       Impact factor: 5.103

Review 5.  Following the cytokine signaling pathway to leukemogenesis: a chronology.

Authors:  Kendall A Smith; James D Griffin
Journal:  J Clin Invest       Date:  2008-11       Impact factor: 14.808

6.  Genetic variation in the RNA transcripts of endogenous virus genes in uninfected chicken cells.

Authors:  S Y Wang; W S Hayward; H Hanafusa
Journal:  J Virol       Date:  1977-10       Impact factor: 5.103

7.  Integration of proviral DNA in chicken cells infected with Schmidt-Ruppin Rous sarcoma virus is not enhanced by DNA repair.

Authors:  T Tsuruo; M A Baluda
Journal:  J Virol       Date:  1977-09       Impact factor: 5.103

8.  Structural protein markers in the avian oncoviruses.

Authors:  C W Rettenmier; H Hanafusa
Journal:  J Virol       Date:  1977-12       Impact factor: 5.103

9.  Distribution of deoxyribonucleic acid complementary to the ribonucleic acid of avian myeloblastosis virus in tissues of normal and tumor-bearing chickens.

Authors:  M A Baluda; W N Drohan
Journal:  J Virol       Date:  1972-11       Impact factor: 5.103

10.  Nuclear DNA sequences present in human leukemic cells and absent in normal leukocytes.

Authors:  W G Baxt; S Spiegelman
Journal:  Proc Natl Acad Sci U S A       Date:  1972-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.